Data sharing in pharma

Statistical guidance for responsible data sharing: an overview

Authors: Christine Fletcher, Sally Hollis, Hans-Ulrich Burger and Christoph Gerlinger

Protecting patient privacy when sharing patient-level data from clinical trials

Greater transparency and, in particular, sharing of patient-level data for further scientific research is an increasingly important topic for the pharmaceutical industry and other organisations who sponsor and...

Authors: Katherine Tucker, Janice Branson, Maria Dilleen, Sally Hollis, Paul Loughlin, Mark J. Nixon and Zoë Williams

Best practice for analysis of shared clinical trial data

Greater transparency, including sharing of patient-level data for further research, is an increasingly important topic for organisations who sponsor, fund and conduct clinical trials. This is a major paradigm ...

Authors: Sally Hollis, Christine Fletcher, Frances Lynn, Hans-Joerg Urban, Janice Branson, Hans-Ulrich Burger, Catrin Tudur Smith, Matthew R. Sydes and Christoph Gerlinger

EFSPI/PSI working group on data sharing: accessing and working with pharmaceutical clinical trial patient level datasets – a primer for academic researchers

Access to patient level datasets from clinical trial sponsors continues to be an important topic for the Pharmaceutical Industry as well as academic institutions and researchers. How to make access to patient ...

Authors: Rebecca Sudlow, Janice Branson, Tim Friede, David Morgan and Caroline Whately-Smith

Data sharing and the evolving role of statisticians

Greater transparency and, in particular, sharing of clinical study reports and patient level data for further research is an increasingly important topic for the pharmaceutical and biotechnology industry and o...

Authors: Nick Manamley, Steve Mallett, Matthew R. Sydes, Sally Hollis, Alison Scrimgeour, Hans Ulrich Burger and Hans-Joerg Urban